protein kinase C inhibitors (Hoechst Marion Roussel)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameprotein kinase C inhibitors (Hoechst Marion Roussel)
Drug Alias Nameprotein kinase C inhibitors (Aventis)105509
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinase C inhibitors
TargetsProtein kinase C
Therapy Area/IndicationsInflammationHypersensitivityHypertension +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAventis Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAventis PharmaHoechst Marion Roussel Ltd
Active IndicationsN/A
Inactive IndicationsInflammationHypersensitivityHypertension +[4] 

Other Information

ATC CodeN/A
Related LinksN/A